Literature DB >> 29799149

Physical functioning and psychological morbidity among regional and rural cancer survivors: A report from a regional cancer centre.

Mari Lashbrook1,2,3, Christina M Bernardes2,3, Marilynne N Kirshbaum4, Patricia C Valery2,3.   

Abstract

OBJECTIVE: To identify factors associated with psychosocial, physical and practical difficulties of daily living and distress among cancer survivors from a regional area in Australia.
DESIGN: Cross-sectional study.
SETTING: Riverina region of southern New South Wales. PARTICIPANTS: The sample included 134 patients who completed treatment for breast, colorectal, lung or cancer at the Riverina Cancer Care Centre. MAIN OUTCOME MEASURES: Distress was assessed by the Distress Thermometer. Psychosocial, physical and practical difficulties of daily living were assessed by the Patient-Reported Outcomes Measurement Information System questionnaires.
RESULTS: A high proportion of cancer survivors had abnormal scores for physical function, sleep disturbance, satisfaction with role, fatigue and pain interference, with many also displaying abnormal scores for anxiety, depression and distress. Survivors living in rural areas and those who had undergone surgery had higher odds of having abnormal scores for sleep disturbance than their counterparts. Living without a partner increased the odds of anxiety and depression. Having advanced disease increased the odds of anxiety and pain. Colorectal cancer and higher education were associated with depression.
CONCLUSION: Monitoring for abnormal physical and psychosocial issues after cancer treatment is essential to maintain or improve psychosocial well-being during survivorship. When developing survivorship care plans for patients residing in regional centres, health professionals should consider availability of high-quality and accessible support services in regional areas of Australia.
© 2018 National Rural Health Alliance Ltd.

Entities:  

Keywords:  breast cancer; cancer; colorectal cancer; distress; lung cancer; prostate cancer; psychosocial

Mesh:

Year:  2018        PMID: 29799149     DOI: 10.1111/ajr.12419

Source DB:  PubMed          Journal:  Aust J Rural Health        ISSN: 1038-5282            Impact factor:   1.662


  5 in total

1.  Comorbidities, treatment-related consequences, and health-related quality of life among rural cancer survivors.

Authors:  Shaila M Strayhorn; Leslie R Carnahan; Kristine Zimmermann; Theresa A Hastert; Karriem S Watson; Carol Estwing Ferrans; Yamilé Molina
Journal:  Support Care Cancer       Date:  2019-07-24       Impact factor: 3.603

2.  Pain management index (PMI)-does it reflect cancer patients' wish for focus on pain?

Authors:  Morten Thronæs; Trude Rakel Balstad; Cinzia Brunelli; Erik Torbjørn Løhre; Pål Klepstad; Ola Magne Vagnildhaug; Stein Kaasa; Anne Kari Knudsen; Tora Skeidsvoll Solheim
Journal:  Support Care Cancer       Date:  2019-07-09       Impact factor: 3.603

Review 3.  Systematic review of sleep and sleep disorders among prostate cancer patients and caregivers: a call to action for using validated sleep assessments during prostate cancer care.

Authors:  Rebecca Robbins; Renee Cole; Chidera Ejikeme; Stephanie L Orstad; Sima Porten; Carolyn A Salter; Tatiana Sanchez Nolasco; Dorice Vieira; Stacy Loeb
Journal:  Sleep Med       Date:  2022-03-31       Impact factor: 4.842

Review 4.  Psychosocial well-being and supportive care needs of cancer patients and survivors living in rural or regional areas: a systematic review from 2010 to 2021.

Authors:  Shannen R van der Kruk; Phyllis Butow; Ilse Mesters; Terry Boyle; Ian Olver; Kate White; Sabe Sabesan; Rob Zielinski; Bryan A Chan; Kristiaan Spronk; Peter Grimison; Craig Underhill; Laura Kirsten; Kate M Gunn
Journal:  Support Care Cancer       Date:  2021-08-14       Impact factor: 3.603

5.  Informing the delivery of cancer survivorship care in rural primary care practice.

Authors:  J R Klemp; C J Knight; B Lowry; T Long; C Bush; K Alsman; H Krebill; D Peereboom; L Overholser; K A Greiner
Journal:  J Cancer Surviv       Date:  2022-02-02       Impact factor: 4.062

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.